Myeloma Minute: Tribute to a Life of Advocacy


| INNOVATION | Latest Research


Saying Goodbye to a Myeloma Patient Advocate Extraordinaire

This week, the global myeloma community is mourning the loss of Aldo Del Col, Co-Founder of Myeloma Canada, valued member of the IMF Board of Directors, and patient advocate extraordinaire. “Aldo inspired everyone around him,” says IMF Chairman Dr. Brian G.M. Durie, who pays tribute to Aldo’s meaningful legacy. “His loss is tragic and profoundly sad, reminding us all that the hard work toward achieving a cure must continue with renewed vigor!”


| INNOVATION | Latest Research


Join the IMF on the Road to the Cure

The International Myeloma Foundation is committed to the search for a cure or cures for multiple myeloma. We invite you to join us on the road to cure. Learn how multiple myeloma experts define cure. Explore the ways in which the IMF’s Black Swan Research Initiative® team is attacking myeloma on all fronts. Scroll through a timeline of the key “Cure Trials” on this road. These trials are called “cure” trials because they use a “curative strategy” that aims to treat myeloma early and aggressively. Dive into this page to discover the heart of the IMF’s mission: “Improving the quality of lives of myeloma patients while working toward prevention and a cure.”


| EDUCATION | Seminar


| INSPIRATION | Race for Myeloma


Early Bird Registration Discounts Extended for the IMF Patient & Family Seminar in Charlotte, NC
Take Part in the 7th Annual Miracles for Myeloma 5K Run/Walk

On September 6-7, 2019, the IMF will host a Patient & Family Seminar at the Westin Charlotte (601 S. College St.) in Charlotte, NC. Choose between two registration packages—either attend Friday’s half-day session and the all-day session Saturday, or attend the Saturday session only. Register NOW as the Early Bird registration discounts have been extended.

The 7th Annual Miracles for Myeloma 5K run/walk will take place on Saturday, September 21, 2019, in Oak Ridge Park, Clark, New Jersey at 9:30 a.m. ET. Last year’s run/walk event raised more than $80,000 to fund the IMF’s research to find a cure. Even if you cannot walk or run that day, there are many ways to contribute. Visit the link below to learn how to register as an individual, as a team, or simply purchase a Remembrance Path sign.

Register Now Button.png


| ACTION | Win a Vacation


A 10-Day Luxury Hawaiian Oasis Is a Winning Raffle Ticket Away

The IMF is hosting a raffle for you to win a 10-day stay at the Villa Ono Oasis in Hawaii. The dates of this paradise vacation are March 16-26, 2020. The winners of this luxury package will receive:

  • A 10-day stay at the Villa Ono Oasis
  • Business-class Airfare for Two on American Airlines to Kailua-Kona, HI
  • A Dolphin Swim Adventure for Two
  • A Manta Ray Night Snorkel for Two
  • A Scuba Instruction Package for Two

Only 1000 raffle tickets will be sold for $50 each: Tickets are selling fast. You can either visit the link below, or contact the IMF’s Karla Lemus at 1-800-452-CURE (2873) to purchase your ticket today. All proceeds will benefit International Myeloma Foundation Research and Programs.


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series




Search the Myeloma Matrix 2.0

Join the conversation about myeloma on the Smart Patients Message Board

Clinical Trial Fact Sheets

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

August 23-24, 2019
IMF Patient & Family Seminar
Los Angeles, CA

September 6, 2019
IMF Patient & Family Seminar
Charlotte, NC

September 7, 2019
Wine Tasting & Tour
Richmond, VA

September 21, 2019
7th Annual Miracles for Myeloma
Clark, New Jersey

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Celgene Corporation, Genentech, and Takeda Oncology

We also thank individuals like you for your continued support!

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.